![Primary Care Inflammatory Bowel Disease Diagnostic Pathway - Faecal Calprotectin (FCp) Testing | GP Portal Primary Care Inflammatory Bowel Disease Diagnostic Pathway - Faecal Calprotectin (FCp) Testing | GP Portal](https://gp-portal.westhampshireccg.nhs.uk/wp-content/uploads/2019/11/FCP-pathway-1-3.png)
Primary Care Inflammatory Bowel Disease Diagnostic Pathway - Faecal Calprotectin (FCp) Testing | GP Portal
![JCM | Free Full-Text | Predictors and Early Markers of Response to Biological Therapies in Inflammatory Bowel Diseases JCM | Free Full-Text | Predictors and Early Markers of Response to Biological Therapies in Inflammatory Bowel Diseases](https://www.mdpi.com/jcm/jcm-10-00853/article_deploy/html/images/jcm-10-00853-g001.png)
JCM | Free Full-Text | Predictors and Early Markers of Response to Biological Therapies in Inflammatory Bowel Diseases
![Pomegranate juice to reduce fecal calprotectin levels in inflammatory bowel disease patients with a high risk of clinical relapse: Study protocol for a randomized controlled trial | Trials | Full Text Pomegranate juice to reduce fecal calprotectin levels in inflammatory bowel disease patients with a high risk of clinical relapse: Study protocol for a randomized controlled trial | Trials | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13063-019-3321-8/MediaObjects/13063_2019_3321_Fig1_HTML.png)
Pomegranate juice to reduce fecal calprotectin levels in inflammatory bowel disease patients with a high risk of clinical relapse: Study protocol for a randomized controlled trial | Trials | Full Text
![EUH Morning Report: What is the utility of fecal calprotectin in the diagnosis and management of inflammatory bowel disease? | The Bottom Line EUH Morning Report: What is the utility of fecal calprotectin in the diagnosis and management of inflammatory bowel disease? | The Bottom Line](https://emorymedicine.files.wordpress.com/2022/02/calprotectin-levels.png)
EUH Morning Report: What is the utility of fecal calprotectin in the diagnosis and management of inflammatory bowel disease? | The Bottom Line
![Gastroenterology Insights | Free Full-Text | Laboratory Assessment of Disease Activity in Pediatric Patients with Inflammatory Bowel Disease: What's New? Gastroenterology Insights | Free Full-Text | Laboratory Assessment of Disease Activity in Pediatric Patients with Inflammatory Bowel Disease: What's New?](https://www.mdpi.com/gastroent/gastroent-11-00009/article_deploy/html/images/gastroent-11-00009-g001.png)
Gastroenterology Insights | Free Full-Text | Laboratory Assessment of Disease Activity in Pediatric Patients with Inflammatory Bowel Disease: What's New?
![Life | Free Full-Text | Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease Life | Free Full-Text | Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease](https://www.mdpi.com/life/life-11-01375/article_deploy/html/images/life-11-01375-g001.png)
Life | Free Full-Text | Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease
![Predicting disease course in ulcerative colitis using stool proteins identified through an aptamer-based screen | Nature Communications Predicting disease course in ulcerative colitis using stool proteins identified through an aptamer-based screen | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-24235-0/MediaObjects/41467_2021_24235_Fig1_HTML.png)
Predicting disease course in ulcerative colitis using stool proteins identified through an aptamer-based screen | Nature Communications
![Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis | The BMJ Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis | The BMJ](https://www.bmj.com/content/bmj/341/bmj.c3369/F3.large.jpg)
Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis | The BMJ
![The role of the mitochondrial protein VDAC1 in inflammatory bowel disease: a potential therapeutic target: Molecular Therapy The role of the mitochondrial protein VDAC1 in inflammatory bowel disease: a potential therapeutic target: Molecular Therapy](https://www.cell.com/cms/attachment/43466b02-a663-4184-a066-a4fd08dd92af/fx1_lrg.jpg)
The role of the mitochondrial protein VDAC1 in inflammatory bowel disease: a potential therapeutic target: Molecular Therapy
![Challenges in the diagnosis and management of inflammatory bowel disease in resource-limited settings in Asia - The Lancet Gastroenterology & Hepatology Challenges in the diagnosis and management of inflammatory bowel disease in resource-limited settings in Asia - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/attachment/1fcb0cb4-ed2f-4595-aa25-6aed83aff0c9/gr1_lrg.jpg)
Challenges in the diagnosis and management of inflammatory bowel disease in resource-limited settings in Asia - The Lancet Gastroenterology & Hepatology
![Simultaneous quantitative profiling of clinically relevant immune markers in neonatal stool swabs to reveal inflammation | Scientific Reports Simultaneous quantitative profiling of clinically relevant immune markers in neonatal stool swabs to reveal inflammation | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-89384-0/MediaObjects/41598_2021_89384_Fig1_HTML.png)